ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
72 hedge funds and large institutions have $10.8M invested in Anthera Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
84% less capital invested
Capital invested by funds: $67M → $10.8M (-$56.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
72
Holding in Top 10
–
Calls
$91K
Puts
$164K
Top Buyers
| 1 | +$476K | |
| 2 | +$235K | |
| 3 | +$162K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$160K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$145K |
Top Sellers
| 1 | -$5.99M | |
| 2 | -$4.6M | |
| 3 | -$3.64M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$2.84M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.02M |